Supply of Ophthalmic Antibiotic Medication (NDC 61314-0645-11)

The contract involves the supply and delivery of six units of Neomycin and Polymyxin B Sulfates and Hydrocortisone Ophthalmic Suspension, USP, 0.35 percent, identified by NDC 61314-0645-11, for use by the U.S. Navy. All units must meet stringent military packaging and labeling standards to ensure compatibility with naval logistics and operational requirements. The medication will be shipped directly to a U.S. Navy fleet replenishment ship, indicating its intended use in austere or deployed maritime environments where access to medical facilities may be limited. This is a subcontract under the Defense Logistics Agency, part of the Department of Defense, with the NAICS code 325412 denoting pharmaceutical preparations manufacturing. The solicitation was posted on July 15, 2026, and the performance location is tied to naval operations at sea, though specific coordinates or ports are not detailed. The contract is managed through the DLA’s DIBBS system, with a designated award and delivery identifier, ensuring traceability and accountability through the military supply chain.